E-pharmacy PharmEasy in talks with Amansa, Blackstone, others to raise $200-M
Mumbai-based PharmEasy's parent entity API Holdings is finalising a USD 200 million primary funding round ahead of its initial public offer (IPO). The company is in talks with investors from the US and South East Asia, including Blackstone, BlackRock, Amansa Capital, Janchor Partners and OrbiMed. The e-pharmacy is also stitching up a secondary transaction of up to USD 100 million, buoyed by high interest from pre-IPO investors looking to come on board. PharmEasy is likely to be valued at around USD 6 billion post the funding round.
Want to receive such news items in your inbox? Click Here to sign up for a trial.